BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.96B |
| 2 |
Coupang
CPNG
|
+$1.77B |
| 3 |
Amazon
AMZN
|
+$1.55B |
| 4 |
International Flavors & Fragrances
IFF
|
+$1.19B |
| 5 |
ConocoPhillips
COP
|
+$1.08B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TIF
Tiffany & Co.
TIF
|
+$1.46B |
| 2 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$1.39B |
| 3 |
DuPont de Nemours
DD
|
+$948M |
| 4 |
Alibaba
BABA
|
+$860M |
| 5 |
CXO
CONCHO RESOURCES INC.
CXO
|
+$852M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.79% |
| 2 | Healthcare | 13.36% |
| 3 | Financials | 12.86% |
| 4 | Consumer Discretionary | 11.91% |
| 5 | Industrials | 8.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2226
British American Tobacco
BTI
$122B
| $94.7M | ﹤0.01% |
2,445,002
-31,348
| -1% | -$1.18M |
|
2227
Theravance Biopharma
TBPH
$880M
| $94.6M | ﹤0.01% |
4,634,135
+142,940
| +3% | +$2.72M |
|
2228
German American Bancorp
GABC
$1.9B
| $94.3M | ﹤0.01% |
2,039,419
+111,739
| +6% | +$4.4M |
|
|
COWN
2229
DELISTED
Cowen Inc. Class A Common Stock
COWN
| $94.2M | ﹤0.01% |
2,680,545
+673,684
| +34% | +$21.7M |
|
|
DTP
2230
DELISTED
DTE Energy Company 2019 Corporate Units
DTP
| $94.1M | ﹤0.01% |
1,894,596
-88,715
| -4% | -$4.22M |
|
|
TBIO
2231
DELISTED
Translate Bio, Inc. Common Stock
TBIO
| $94.1M | ﹤0.01% |
5,707,412
+266,772
| +5% | +$6.08M |
|
2232
Castle Biosciences
CSTL
$982M
| $93.4M | ﹤0.01% |
1,363,836
+222,089
| +19% | +$16.7M |
|
2233
KraneShares Bosera MSCI China A 50 Connect Index ETF
KBA
$149M
| $92.5M | ﹤0.01% |
2,089,961
-29,470
| -1% | -$1.4M |
|
2234
Prudential
PUK
$34.4B
| $92.3M | ﹤0.01% |
2,229,657
+2,229,343
| +709,982% | +$84.9M |
|
2235
iShares Core Moderate Allocation ETF
AOM
$1.78B
| $92.2M | ﹤0.01% |
2,116,890
+151,121
| +8% | +$6.58M |
|
|
FMTX
2236
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
| $92.2M | ﹤0.01% |
3,289,576
+654,826
| +25% | +$23.6M |
|
|
SPPI
2237
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $91.8M | ﹤0.01% |
28,173,428
+352,449
| +1% | +$1.26M |
|
|
SHYF
2238
DELISTED
The Shyft Group
SHYF
| $91.8M | ﹤0.01% |
2,468,593
+35,308
| +1% | +$1.18M |
|
2239
National Presto Industries
NPK
$995M
| $91.4M | ﹤0.01% |
895,892
+49,374
| +6% | +$4.86M |
|
2240
Rayonier Advanced Materials
RYAM
$583M
| $91.4M | ﹤0.01% |
10,082,038
+667,605
| +7% | +$5.74M |
|
2241
ATN International
ATNI
$478M
| $91.3M | ﹤0.01% |
1,859,463
+84,578
| +5% | +$4.01M |
|
|
LDL
2242
DELISTED
Lydall, Inc.
LDL
| $91.3M | ﹤0.01% |
2,706,031
+117,884
| +5% | +$4.03M |
|
2243
iShares Ultra Short Duration Bond Active ETF
ICSH
$8.4B
| $90.8M | ﹤0.01% |
1,797,963
-384,912
| -18% | -$19.4M |
|
2244
American Vanguard Corp
AVD
$66.4M
| $90.8M | ﹤0.01% |
4,448,607
+190,095
| +4% | +$3.62M |
|
|
EVRI
2245
DELISTED
Everi Holdings
EVRI
| $90.4M | ﹤0.01% |
6,406,299
+389,971
| +6% | +$5.55M |
|
|
VRTV
2246
DELISTED
VERITIV CORPORATION
VRTV
| $90.4M | ﹤0.01% |
2,124,151
+184,713
| +10% | +$5.3M |
|
2247
Prothena Corp
PRTA
$468M
| $90.2M | ﹤0.01% |
3,591,008
-101,962
| -3% | -$1.92M |
|
2248
CALL
Western Digital
WDC
$159B
| $90.1M | ﹤0.01% |
1,786,050
+879,795
| +97% | +$41.1M |
|
2249
Omeros
OMER
$982M
| $90.1M | ﹤0.01% |
5,060,455
-323,567
| -6% | -$6.29M |
|
2250
Corsair Gaming
CRSR
$1.38B
| $89.8M | ﹤0.01% |
2,698,189
+241,086
| +10% | +$8.97M |
|
Similar funds
BlackRock's Q1 2021 Portfolio in Review
As of Q1 2021, BlackRock held 5,453 positions worth $3.4T, up 8.5% from $3.13T the previous quarter. Its ten largest holdings account for 17% of the portfolio.
BlackRock's Q1 2021 filing shows 377 new, 3,642 increased, 849 reduced and 151 closed positions. Its largest new stake was Coupang: 38,242,925 shares worth $1.89B. The largest sale was Tiffany & Co., an estimated $1.46B.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q1 2021 buy was Coupang: 38,242,925 shares worth $1.89B.
- BlackRock added most to State Street SPDR S&P 500 ETF Trust in Q1 2021, an estimated $4.96B increase.
- BlackRock's biggest Q1 2021 reduction was iShares iBoxx $ High Yield Corporate Bond ETF, cutting an estimated $1.39B.
- BlackRock fully exited Tiffany & Co. in Q1 2021, selling an estimated $1.46B.
- BlackRock's ten largest holdings make up 17% of its $3.4T portfolio in Q1 2021.
- BlackRock opened 377 new positions and closed 151 in Q1 2021.
- BlackRock's portfolio value rose 8.5% quarter-over-quarter to $3.4T.
Based on BlackRock's 13F filing for Q1 2021, filed 7 May 2021.